Trial
NCT05249569
Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Texas Southwestern Medical Center
Collaborators
Pfizer
Condition
Hepatocellular Carcinoma
Intervention
Axitinib
Why stopped
Sponsor pulled support for one of the study drugs.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-05-03